Key points are not available for this paper at this time.
Introduction Replicated evidence indicates that ketamine and esketamine reduces measures of suicidality in persons with treatment resistant depression (TRD). It remains uncertain whether susceptible individuals may experience worsening of pre-existing suicidality with either agent.
McIntyre et al. (Mon,) studied this question.